Next Post

MGC Pharma strikes $15m funding deal with US fund

Thu Sep 10 , 2020
ASX-listed MGC Pharmaceuticals has struck a significant funding deal with US-based investment group, Mercer Street Global Opportunity Fund, that allows the medicinal marijuana company to draw on a financing facility of up to $15 million to accelerate its clinical trial and research programs.